About
Technology
Issues
FAQ
Links
Official Page
Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.